Evidence map›Paper›PMID 41843898›Full record

ArticlePLoS computational biology2026

TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics.

Chenxuan Zang, Charles C Guo, Yaohong Wang, Peng Wei, Ziyi Li

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenxuan ZangDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID https://orcid.org/0000-0001-5237-0351
Charles C GuoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Yaohong WangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Peng WeiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Ziyi LiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID https://orcid.org/0000-0001-8359-0533

Funding

Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
Project 3: Identifying Molecular Vulnerabilities to Improve Interferon Gene Therapy in Bladder CancerP01CA296429 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BOGDAN A CZERNIAK, David J. McConkey · 2025 to 2026
$6.1M
Coordinating and Data Management Center for Translational and Basic Science Research in Early LesionsU24CA274212 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Liang Li, Ying Yuan · 2022 to 2026
$3.5M
Statistical methods to delineate the spatial and temporal pattern of cell-cell interactions in Spatial Transcriptomics dataR35GM159819 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Ziyi Li · 2025 to 2026
$899k
NCI NIH HHS P01 CA296429NCI NIH HHS P50 CA127001NCI NIH HHS U24 CA274212NIGMS NIH HHS R35 GM159819
6 · The paper itself

Abstract

The identification of tumor cells is pivotal for understanding tumor heterogeneity and the tumor microenvironment. Recent advances in spatially resolved transcriptomics (SRT) have revolutionized the way that transcriptomic profiles are characterized and have enabled the simultaneous quantification of transcript locations in intact tissue samples. SRT is a promising alternative method to study gene expression patterns in spatial domains. Nevertheless, the precise detection of tumor regions within intact tissue remains a great challenge. A common strategy for identifying tumor cells is via tumor-specific marker gene expression signatures, which are highly dependent on marker accuracy. Another effective approach is through aneuploid copy number alterations, as most types of cancer exhibit copy number abnormalities. Here, we introduce a novel computational method, called TUSCAN (TUmor Segmentation and Classification ANalysis in spatial transcriptomics), which constructs a spatial copy number variation profile to improve the accuracy of tumor region identification. TUSCAN combines gene information from SRT data and hematoxylin-and-eosin-staining image to annotate tumor sections and other benign tissues. We benchmark the performance of TUSCAN and several existing methods through the application to multiple datasets from different SRT platforms. We demonstrate that TUSCAN can effectively delineate tumor regions, with improved accuracy compared to other approaches. Additionally, the output of TUSCAN provides interpretable clonal evolution inferences that may lead to novel insights into disease development and potential druggable targets.

Indexed as

Gene Expression ProfilingNeoplasmsAlgorithmsBiomarkers, TumorClassification AlgorithmsComputational BiologyDNA Copy Number VariationsHumansSpatial TranscriptomicsTranscriptomeTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID41843898
PMCPMC12995303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.